Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway

  • Jinrun Wang
  • Yang Liu
  • Yanze Li
  • Lizhe Xu
  • Jinzhuo Ning
  • Haoyong Li
Open at sourcePDFDOICite

Related

  1. AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling.
    Mingzhe Xu, Xiaohang Song, Kudusi +4
    BMC medical genomicsPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCPMC
  3. DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Box C/D SNORD116-17 promotes prostate cancer progression by targeting the miR-206/E2F5 axis
    Xiuyi Pan, Yifan Kang, Jinjing Zhong +9
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationOncologyCell PressCrossrefEurope PMC
  5. CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
    Di Wu, Haonan Zhou, Shiqi Liu +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{wang2026jarid2,
  title = {{JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway}},
  author = {Jinrun Wang and Yang Liu and Yanze Li and Lizhe Xu and Jinzhuo Ning and Haoyong Li},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-76159-8},
  url = {https://www.nature.com/articles/s41598-026-76159-8},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
AU  - Jinrun Wang
AU  - Yang Liu
AU  - Yanze Li
AU  - Lizhe Xu
AU  - Jinzhuo Ning
AU  - Haoyong Li
PY  - 2026
DA  - 2026/10/21
JO  - Scientific Reports
DO  - 10.1038/s41598-026-76159-8
UR  - https://www.nature.com/articles/s41598-026-76159-8
SN  - 2045-2322
ER  -